Phrontline Biopharma
China - ShanghaiPharmaceutical
Focus: Phrontline Biopharma is an oncology-focused biotech company pioneering bispecific dual-payload antibody-drug conjugates (ADCs) from its Shanghai headquarters. The company operates in a highly specialized segment with a single early-stage program in clinical development.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About Phrontline Biopharma
AI assessmentNot HiringNo open roles listed right now. Follow Phrontline Biopharma to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
TJ101
Lung Cancer (NSCLC)Clinical Trials (1)
NCT07181473A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of TJ101 in Patients With Advanced/Metastatic Solid Tumors
Phase 1Help build intelligence for Phrontline Biopharma
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.